|1||Not yet recruiting||
Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis
|2||Active, not recruiting||
Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
† Study has passed its completion date and status has not been verified in more than two years.